RUNX1 and Burkitt lymphoma: In samples classified with B-cell t(9:22) BCR/ABL, t(4:11) MLL/AFF1, t(12:21) TEL/AML1 and T-cell lymphoblastic leukemias or follicular and Burkitt lymphomas we identified very variable methylation at the promoters, which was often significantly different from normal controls but not reaching the defined 40% methylation cut-off (Figure 4A, C).